Page last updated: 2024-09-03

b 823-08 and sincalide

b 823-08 has been researched along with sincalide in 1 studies

Compound Research Comparison

Studies
(b 823-08)
Trials
(b 823-08)
Recent Studies (post-2010)
(b 823-08)
Studies
(sincalide)
Trials
(sincalide)
Recent Studies (post-2010) (sincalide)
8104,01572533

Protein Interaction Comparison

ProteinTaxonomyb 823-08 (IC50)sincalide (IC50)
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.0006
Cholecystokinin receptor type AHomo sapiens (human)0.0006
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.001
Gastrin/cholecystokinin type B receptorMus musculus (house mouse)0.0008
Cholecystokinin receptor type ACavia porcellus (domestic guinea pig)0.0004

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, R; Eissele, R; Koop, H; Koop, I; Meyer, F; Mössner, J; Patberg, H; Richter, S1

Other Studies

1 other study(ies) available for b 823-08 and sincalide

ArticleYear
A new CCK-B/gastrin receptor antagonist acts as an agonist on the rat pancreas.
    International journal of pancreatology : official journal of the International Association of Pancreatology, 1994, Volume: 15, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amino Acid Sequence; Amylases; Analysis of Variance; Animals; Benzodiazepinones; Devazepide; Drug Interactions; Female; In Vitro Techniques; Indoles; Molecular Sequence Data; Omeprazole; Pancreas; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide

1994